NASDAQ:ZJYL Jin Medical International Q2 2026 Earnings Results & Report $2.06 -0.06 (-2.83%) Closing price 10/9/2026 04:00 PM EasternExtended Trading$2.05 -0.01 (-0.34%) As of 10/9/2026 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Jin Medical International reported Q2 2026 earnings on August 4, 2026. The company reported EPS of -$0.01, while revenue was $4.46 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ2 2026Report DateAugust 4, 2026TimeBefore Market Opens Jin Medical International EPS ResultsActual EPS-$0.01Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AJin Medical International Revenue ResultsActual Revenue$4.46 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesEarnings HistoryCompany Profile Jin Medical International Q2 2026 Earnings FAQ Did Jin Medical International beat earnings estimates for Q2 2026? Jin Medical International (NASDAQ:ZJYL) reported earnings of -$0.01 per share for Q2 2026. The report was announced on Tuesday, August 4, 2026. What was Jin Medical International's revenue for Q2 2026? Jin Medical International reported revenue of $4.46 million for Q2 2026. Jin Medical International Earnings HeadlinesJin Medical International (NASDAQ:ZJYL) Shares Climb 2.1% - Here's What HappenedOctober 6, 2026 | americanbankingnews.comJin Medical International Closes US$159 Million VIE Acquisition with Major Share IssuanceSeptember 24, 2026 | tipranks.comYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.October 11 at 1:00 AM | Profits Run (Ad)Jin Medical International to Acquire Control of Ginseng-Tech Assets via US$159 Million VIE DealSeptember 8, 2026 | tipranks.comJin Medical International Ltd. Class AAugust 6, 2026 | edition.cnn.comJin Medical International (ZJYL) stock soars over 63% after hours: Here's what you need to knowAugust 5, 2026 | msn.comSee More Jin Medical International Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Jin Medical International? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Jin Medical International and other key companies, straight to your email. Email Address About Jin Medical InternationalJin Medical International (NASDAQ:ZJYL) Limited is a China-based medical equipment company that develops, manufactures and sells mobility and daily-living aid products. Its product portfolio primarily includes electric and manual wheelchairs, along with other equipment designed to support mobility and personal care. The company sells its products through business-to-business and other distribution channels, serving customers in China and international markets. Its offerings are intended for use by individuals with mobility limitations, older adults and people requiring assistance with everyday activities. Jin Medical International is incorporated in the Cayman Islands and conducts its operating activities through subsidiaries in China. The company became publicly traded on the Nasdaq Capital Market under the symbol ZJYL in 2023.View Jin Medical International ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 10/05 - 10/09Delta Air Lines Faces a Fuel Crisis—But There's a Silver LiningPalantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November EarningsApplied Digital’s Hidden Moat Could Unlock Massive UpsideLevi's Stock Dip Reveals Value Opportunity Despite Q3 HeadwindsTilray Finds a Path to Growth Without Waiting on U.S. Cannabis ReformPepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value Upcoming Earnings Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
